KLOW
Regenerative & Inflammation-Modulation Research
$48.00
Out of stock
Product Description
KLOW is a research-grade peptide blend combining GHK-Cu (Copper Tripeptide-1), BPC-157 (Body Protection Compound-157), TB-500 (Thymosin Beta-4 fragment), and KPV (Lys-Pro-Val) into a single formulation for multi-pathway laboratory investigation. This blend builds upon regenerative research frameworks by incorporating peptides studied for tissue remodeling, angiogenic signaling, cellular migration, and immune modulation.
Researchers study KLOW to explore wound-healing mechanisms, extracellular matrix remodeling, inflammatory signaling pathways, connective tissue response, and gastrointestinal mucosal models in controlled experimental environments. Combining four complementary peptides enables investigation of interacting biological pathways relevant to regenerative and inflammation-focused research designs.
This product is supplied strictly for laboratory and scientific research purposes. It is not intended for human or animal use, and is not designed for therapeutic, diagnostic, or clinical applications.
Important Notice
For research purposes only. Not for human or animal use & not FDA-approved.
By purchasing, you confirm you are 21 years of age or older and a qualified researcher.
Multi-pathway research blend targeting regeneration, angiogenesis, and inflammatory signaling
Includes four well-studied peptides frequently referenced in tissue repair and immune research
High purity (≥98%) for each component to support reproducible experimental outcomes
Lyophilized, single-vial format for consistency across studies
Batch verified for identity, purity, and structural integrity
Tissue Repair & Regenerative Pathways
Research models investigate how BPC-157 and TB-500 may influence angiogenic signaling, fibroblast activity, and cell migration, while GHK-Cu is examined for its role in collagen remodeling and extracellular matrix regulation.
Inflammatory & Immune Modulation
KLOW is studied for interactions between KPV and BPC-157 and inflammatory signaling pathways, including cytokine-associated and NF-κB-related mechanisms in experimental inflammation models.
Skin & Connective Tissue Research
Preclinical studies explore GHK-Cu–associated dermal regeneration, connective tissue remodeling, and scar-related pathways, supporting dermatology and wound-healing research frameworks.
Gastrointestinal & Mucosal Integrity Models
Research evaluates BPC-157-related epithelial protection mechanisms alongside KPV-associated immune signaling, contributing to studies of gastrointestinal inflammation and mucosal barrier function.
References
Pickart L et al. (2015). GHK-Cu and collagen remodeling in wound healing.
Journal of Investigative Dermatology
https://www.jidonline.org/article/S0022-202X%2815%2940514-7/fulltextSikiric P et al. (2018). BPC-157 and inflammatory modulation in preclinical models.
Current Pharmaceutical Design
https://repozitorij.kb-merkur.hr/islandora/object/kbmerkur%3A94Siméon A et al. (2000). Anti-inflammatory properties of copper tripeptide in skin models.
Inflammation Research
https://link.springer.com/article/10.1007/s00011-010-0214-4Goldstein AL et al. (2012). Role of thymosin beta-4 in angiogenesis and tissue repair.
Annals of the New York Academy of Sciences
https://link.springer.com/content/pdf/10.1007/s10456-007-9077-x.pdf
